NCT02097875View on ClinicalTrials.gov

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Skin Neoplasms
Interventions
DRUG

BLZ-100

Trial Locations (1)

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

All Listed Sponsors
lead

Blaze Bioscience Australia Pty Ltd

INDUSTRY

NCT02097875 - Safety Study of a Fluorescent Marker to Visualize Cancer Cells | Biotech Hunter | Biotech Hunter